ライフサイエンスコーパス: chylothorax

1 g of the stapler line, one rethoracotomy for chylothorax).

2 that subsequently lead to chylous ascites or chylothorax.

3 ymphatic collecting vessels, lymphedema, and chylothorax.

4 deficiency could be one cause of congenital chylothorax.

5 gous mutant mice died perinatally exhibiting chylothorax.

6 n completion and were more likely to develop chylothorax (12% [three of 24] vs 75% [six of eight]; P

7 were 8.8% versus 11.3% (P=0.228), with more chylothorax (2.5% vs 0.7%; P=0.030) and trend toward mor

8 en groups (24.6% vs 22.5%; P=0.291), whereas chylothorax (2.5% vs 1.2%; P=0.020), cardiovascular comp

9 aphy, we identified 3 distinct etiologies of chylothorax: 2 patients (8%) with traumatic leak from a

10 imaging findings, determine the mechanism of chylothorax after cardiac surgery, and analyze the outco

11 Complications consisted of 1 postoperative chylothorax and 3 episodes of feeding intolerance.

12 nts with CLFD were not successful to resolve chylothorax and alternate approaches need to be develope

13 lymphatic fistula (n = 2; 8%), and combined chylothorax and chylous ascites (n = 4; 16%).

14 of primary lymphedema, secondary lymphedema, chylothorax and chylous ascites, lymphatic malformations

15 Most patients in this study had nontraumatic chylothorax and dynamic contrast-enhanced magnetic reson

16 rrhage, recurrent laryngeal nerve paralysis, chylothorax, and tracheal laceration (<1% each).

17 rrhage, recurrent laryngeal nerve paralysis, chylothorax, and tracheal laceration, <1% each.

18 ry syndrome; ileus; pnemothorax; hemothorax; chylothorax; and fat embolism.

19 nd may present with nonimmune fetal hydrops, chylothorax, chylous ascites, or lymphedema.

20 psis, renal failure, pulmonary hypertension, chylothorax, diaphragm paresis, and arrhythmia.

21 Rapid, consistent appearance of chylothorax enabled us to examine the step-by-step devel

22 promoter adiponectin (ADN), to determine how chylothorax forms.

23 Chylous pleural effusion (chylothorax) frequently accompanies lymphatic vessel mal

24 RECENT FINDINGS: The incidence of chylothorax has been increasing over the last two decade

25 thrombosis in 64, Atrial fibrillation in 42, chylothorax in 24, Empyema in 23, pneumonia in 21, Hemot

26 Together, the findings indicate that chylothorax in ADN-VEGF-C mice results from retrograde f

27 article is to review the pathophysiology of chylothorax in patients after surgery for congenital hea

28 considered a potential mechanism underlying chylothorax in patients and mouse models, the path chyle

29 Post-operative chylothorax in patients with congenital heart disease is

30 PURPOSE OF REVIEW: Postoperative chylothorax is a frequently encountered pathology in the

31 Chylothorax is commonly seen in children after surgery f

32 Currently, the etiology of chylothorax is poorly understood and treatment options a

33 ia and leakage and early lethality caused by chylothorax (lymphatic fluid accumulation in the pleural

34 Indications were chylothorax (n = 19; 76%), cervical lymphatic fistula (n

35 Chylothorax occurred in 28 patients (5.4%), vocal cord d

36 hemostasis exhibit lymphedema and sometimes chylothorax phenotypes indicative of lymphatic insuffici

37 c duct and cisterna chyli, and presenting as chylothorax, pleural effusions, chylous ascites, and lym

38 14 was accompanied by respiratory distress, chylothorax, pulmonary lymphangiectasia, and high mortal

39 k4 in mice causes postnatal lethality due to chylothorax, suggesting that Map4k4 is required for norm

40 congenital heart disease and post-operative chylothorax who presented for lymphatic imaging and inte

41 All 16 patients had resolution of chylothorax, with a median of 7.5 days from intervention

42 gly, 100% of adult ADN-VEGF-C mice developed chylothorax within 7 days.